KIF5A and amyotrophic lateral sclerosis: We also provided evidence for a combined gain/loss of function pathomechanism unexpectedly shared by two frameshift mutants associated with ALS and NEIMY, that would bridge the dichotomy between KIF5A-linked neurodevelopmental and neurodegenerative conditions.